Log in

LON:IDPInnovaderma Share Price, Forecast & News

GBX 84.90
+1.40 (+1.68 %)
(As of 06/2/2020 04:09 AM ET)
Add
Compare
Today's Range
84.90
Now: GBX 84.90
84.90
50-Day Range
39.50
MA: GBX 62.37
84
52-Week Range
30
Now: GBX 84.90
115
Volume4,099 shs
Average Volume81,503 shs
Market Capitalization£12.31 million
P/E Ratio10.88
Dividend YieldN/A
BetaN/A
InnovaDerma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of clinically proven products in life sciences, beauty, and personal care products in the United Kingdom, Europe, the United States, Australasia, North Asia, and Africa. The company offers a range of men's skincare products, including hand and body washes, hand creams, face washes, and face moisturizers under the Charles + Lee brand name; and shampoos, conditioners, and laser technology treatments to treat male and female hair loss, alopecia, and thinning hair under the Leimo brand name. It also provides tanning mousses, tanning gels, tanning oils, primers, moisturizers, and applicators under the Skinny Tan brand name; cosmetics, such as lipsticks and eyeshadows under the Stevie K brand name; Prolong, a Class II medical device for the treatment of premature ejaculation; and haircare products comprising shampoos, conditioners, and spray treatment for men and women to aid hair regrowth and hair thickening under the Roots brand name. The company sells its products through online DTC channel, and international retail and distribution partners. InnovaDerma PLC was incorporated in 2014 and is headquartered in London, the United Kingdom.
Read More
Innovaderma logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.35 out of 5 stars


Industry, Sector and Symbol

Industry Specialty Retail
Sub-IndustryN/A
SectorConsumer Cyclical
CUSIPN/A
CIKN/A
Phone61 3 9863 8030

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£14.12 million
Cash FlowGBX 2.87 per share
Book ValueGBX 69.60 per share

Profitability

Miscellaneous

Employees34
Market Cap£12.31 million
Next Earnings DateN/A
OptionableNot Optionable

Receive IDP News and Ratings via Email

Sign-up to receive the latest news and ratings for IDP and its competitors with MarketBeat's FREE daily newsletter.

Innovaderma (LON:IDP) Frequently Asked Questions

How has Innovaderma's stock been impacted by COVID-19 (Coronavirus)?

Innovaderma's stock was trading at GBX 48.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IDP stock has increased by 75.1% and is now trading at GBX 84.90. View which stocks have been most impacted by Coronavirus.

How were Innovaderma's earnings last quarter?

Innovaderma PLC (LON:IDP) issued its quarterly earnings data on Tuesday, February, 25th. The company reported ($2.00) EPS for the quarter. View Innovaderma's earnings history.

Has Innovaderma been receiving favorable news coverage?

Press coverage about IDP stock has trended very positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Innovaderma earned a media sentiment score of 3.5 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutInnovaderma.

Who are some of Innovaderma's key competitors?

What other stocks do shareholders of Innovaderma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innovaderma investors own include Sol Gel Technologies (SLGL), Synovus Financial (SNV), Venator Materials (VNTR), BJ's Restaurants (BJRI), Christopher & Banks (CBK), CareDx (CDNA), Cidara Therapeutics (CDTX), eHealth (EHTH), FLIR Systems (FLIR) and Imperial Brands (IMB).

Who are Innovaderma's key executives?

Innovaderma's management team includes the following people:
  • Mr. Haris Chaudhry FAIM, MAICD, Founder & Exec. Chairman
  • Mr. Kieran Callan, CEO & Exec. Director
  • Mr. Joseph Bayer FCPA, GAICD, Exec. Director

What is Innovaderma's stock symbol?

Innovaderma trades on the London Stock Exchange (LON) under the ticker symbol "IDP."

How do I buy shares of Innovaderma?

Shares of IDP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Innovaderma's stock price today?

One share of IDP stock can currently be purchased for approximately GBX 84.90.

How big of a company is Innovaderma?

Innovaderma has a market capitalization of £12.31 million and generates £14.12 million in revenue each year. Innovaderma employs 34 workers across the globe.

What is Innovaderma's official website?

The official website for Innovaderma is www.innovaderma.com.

How can I contact Innovaderma?

The company can be reached via phone at 61 3 9863 8030.

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.